Trump’s 200% Generic Drug Tariff Plan Puts India’s Pharma Exports in Focus
US President Donald Trump has announced a phased tariff policy on imported generic medicines, proposing duties of up to 200%…
US Market
Read More
Tariff Rollbacks, Trade Deals Reshape Cost Dynamics of Indian Healthcare Sector
Recent tariff revisions and the scrapping of punitive duties by key global partners are beginning to reshape India’s healthcare and…
Indian MedTech Firms Eye US Market as China Loses Edge
Indian MedTech manufacturers are spotting an opening to replace Chinese suppliers and expand their footprint in the lucrative US market….